|Mr. J. Michael Carmena||Chief Financial Officer||8.64k||N/A||61|
|Ms. Cathy Bradshaw||Pres of Wound Care Innovations LLC||120k||N/A||64|
|Dr. Jane A. Fore M.D.||Chief Medical Officer||N/A||N/A||N/A|
|Karin K. Delapp||Controller||N/A||N/A||N/A|
Wound Management Technologies, Inc., together withs itssubsidiaries, develops, markets, and distributes collagen-based wound care products to physicians, clinics, and hospitals in the United States. The company offers CellerateRX, a medical device for use on various acute and chronic wounds in gel and powder form. It also holds patents for a resorbable bone wax and delivery system for orthopedic bone void fillers. The company was formerly known as MB Software, Inc. and changed its name to Wound Management Technologies, Inc. in May 2008. Wound Management Technologies, Inc. was founded in 1982 and is based in Fort Worth, Texas.
Wound Management Technologies, Inc.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.